China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) 3-1 said at the performance communication meeting that online business accounts for a relatively small proportion of the company’s business. At present, online business accounts for about 4% of CHC business, which is still not high, mainly related to the company’s product structure, but the business has grown rapidly in the past few years. It is expected that the online business is expected to reach about 10% in the future. At present, the speed of filing provincial and national standards for formula particles is relatively slow, and there are great differences in policies among provinces. For example, Fujian adopts the method of publicly listing the price of formula particles. The company adopts one province and one policy as the response plan. It is expected that the price adjustment and sales trend of formula particles will be clearer in the second quarter of this year. The cost of national standard varieties of formula granules has increased significantly, and the national standard is relatively high. Centralized mining is piloted locally. It is expected that the conditions for national promotion will not be met in the short term. The company actively pays attention to the progress of centralized mining in Shandong. In the process of switching between the old and new national standards, it is expected that the income growth in the first half of this year will be affected to some extent, and the annual growth rate is expected to be slightly lower than that in previous years. The risk of centralized purchase of chemical drug varieties of the company has been basically weakened. The centralized collection of traditional Chinese medicine is still in the pilot process and has not been implemented nationwide. Traditional Chinese medicine injection was involved in the previous centralized purchase pilot, and the proportion of this business in the company’s revenue has decreased to about 4%.
© China Stock Market News